Table 1. Patient Characteristics at BMT... | American Society of Hematology

Table 1.

Patient Characteristics at BMT

Variable	Allogeneic BMT	Autologous BMT

No.	10	18
Age (yr), median (range)	43 (31-55)	47 (28-60)
Male/female	6/4	7/11
Stage of disease
III	0	2
IV	10	16
Tumor histology^*
FSC	0	2
FM	6	16
SL	4	0
No. of prior chemotherapy regimens, median (range)	2 (2-4)	3 (2-5)
BM involvement^†	10	2
Status of disease^‡
Sensitive	3	18
Resistant	7	0

Variable	Allogeneic BMT	Autologous BMT

No.	10	18
Age (yr), median (range)	43 (31-55)	47 (28-60)
Male/female	6/4	7/11
Stage of disease
III	0	2
IV	10	16
Tumor histology^*
FSC	0	2
FM	6	16
SL	4	0
No. of prior chemotherapy regimens, median (range)	2 (2-4)	3 (2-5)
BM involvement^†	10	2
Status of disease^‡
Sensitive	3	18
Resistant	7	0

According to the classification of the Working Formulation: FSC, follicular small cleaved cell; FM, follicular mixed small cleaved and large cell; SL, small lymphocytic.

†

Analyzed by histopathologic examination of two-sided iliac crest biopsies.

‡

Response to the final chemotherapy before BMT.

View Large

This Feature Is Available To Subscribers Only